Clinical Trial Update: ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 trial of ABT-888 (veliparib) in combination with a modified FOLFOX6 regimen for metastatic pancreatic cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• ABT-888 (veliparib) (veliparib)
• Leucovorin (folinic acid)
• Modified FOLFOX6 regimen
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Georgetown University | Conditions: Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-06